Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 138
- Registration Number
- NCT06440746
- Locations
- 🇷🇺
Regional Clinical Hospital Regional state budgetary healthcare institution, Barnaul, Russian Federation
🇷🇺Ural research Institute of Phthisiopulmonology, Ekaterinburg, Russian Federation
🇷🇺Budgetary healthcare institution of the Voronezh region "Voronezh Regional Clinical Hospital No1", Voronezh, Russian Federation
Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis
- Conditions
- Interventions
- First Posted Date
- 2023-01-06
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 17
- Registration Number
- NCT05673902
- Locations
- 🇷🇺
National medical research center named after V. A. Almazov, Saint Petersburg, Russian Federation
Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)
- Conditions
- Interventions
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- R-Pharm International, LLC
- Registration Number
- NCT05432960
- Locations
- 🇷🇺
FGBU "National Medical Research Center named after V.A. Almazov", Ministry of Health of the Russian Federation, Department of Rheumatology, St. Petersburg, Russian Federation
🇷🇺State Budgetary Institution of Healthcare Leningrad Regional Clinical Hospital, Department of Rheumatology, St. Petersburg, Russian Federation
🇷🇺Research Institute of Rheumatology. V.A. Nasonova, Moscow, Russian Federation
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT05190991
- Locations
- 🇦🇲
Center of Medical Genetics and Primary Health Care LLC, Yerevan, Armenia
🇷🇺FSBEI HE First Moscow State Medical University named after I.M. Sechenov, Moscow, Russian Federation
🇷🇺Moscow Multidisciplinary Scientific and Clinical Center named after S.P. Botkin, Moscow, Russian Federation
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
- Conditions
- Interventions
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 84
- Registration Number
- NCT05092776
- Locations
- 🇷🇺
Saint-Petersburg Pasteur Institute, Saint-Petersburg, Russian Federation
🇷🇺Terafarm, Llc, Stavropol, Russian Federation
🇹🇷Hacettepe University Faculty of Medicine, Ankara, Turkey
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04692766
- Locations
- 🇷🇺
Federal State Budget Institution "V.A. Almazov National Medical Research Center" of Ministry of Healthcare of Russian Federation, Saint Petersburg, Russian Federation
🇷🇺Federal Budgetary Healthcare Institution Orenburg Regional Clinical Hospital, Orenburg, Russian Federation
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)
- Conditions
- Interventions
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 372
- Registration Number
- NCT04380519
- Locations
- 🇷🇺
State Budget Healthcare Institution "City Clinical Hospital â„– 15 named after O.M. Filatov" of Moscow City Healthcare Department, Moscow, Russian Federation
🇷🇺Moscow State Budget Institution of Healthcare "Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare", Moscow, Russian Federation
🇷🇺Saint-Petersburg State Budget Institution of Healthcare "City Hospital №40", Saint Petersburg, Russian Federation
Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4
- Conditions
- Interventions
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 17
- Registration Number
- NCT04246762
- Locations
- 🇧🇬
Comac Medical Ltd, Sofia, Bulgaria
🇲🇩ICS ARENSIA Exploratory Medicine SRL, a daughter company of ARENSIA Exploratory Medicine GmbH,Republican Clinical Hospital, Chisinau, Moldova, Republic of
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2017-04-19
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 2106
- Registration Number
- NCT03120949
- Locations
- 🇺🇸
C.V Mehta MD Med Corp.., Hemet, California, United States
🇺🇸New England Research Associates LLC, Bridgeport, Connecticut, United States
🇺🇸Family Clinical Trials, LLC., Pembroke Pines, Florida, United States
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
- Conditions
- Interventions
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- R-Pharm International, LLC
- Target Recruit Count
- 1648
- Registration Number
- NCT02760407
- Locations
- 🇺🇸
Reliable Clinical Research, LLC, Hialeah, Florida, United States
🇺🇸Valerius Medical Group, Los Alamitos, California, United States
🇺🇸Physician Resrch Collaboration, Lincoln, Nebraska, United States